The coronavirus is associated with a group of RNA viruses responsible for serious respiratory diseases that can have an impact on humans and animals. The coronavirus is commonly caused by COVID-19. Mainly associated with animals, the coronavirus created a pandemic when the first case of human infection was recorded in 2019.
As more human infections began to be recorded around the globe, millions of lives were lost to the ravishing affects of the underlining respiratory disease and COVID pneumonia. Without a vaccine, many people were left without a way to fight off the deadly virus.
Many children and adults with underlining issues like obesity and asthma were left highly vulnerable to the virus. They were very susceptible to being placed on a ventilator and at a higher risk of death from the coronavirus.
There was a pill regimen and IV therapy being used to alleviate the symptoms of the virus. In fact, social distancing and masks were also used to slow the spread of COVID-19. To date, over 5+ million people have died from the coronavirus, but diagnosed cases of COVID and hospitalization as a result of the virus have been on a steady decline.
How Infectious Is COVID Pneumonia?
Pneumonia is a result of an infection that causes inflammation of the airs sacs in the lungs. The lungs can also fill with fluid making it hard to breathe. As a result of a COVID-19, an individual is at a higher risk of catching pneumonia. With the coronavirus, pneumonia becomes significantly deadlier. According to WebMD, “COVID pneumonia lasts longer and has more deadly affects” when compared to traditional pneumonia. COVID pneumonia spreads very rapidly which leaves any treatment hard to fight off the virus and is responsible for most fatalities.
Take a look at the short video clip below to learn more about COVID-19 pneumonia:
What Is The COVID-19 Vaccine?
Created under high scrutiny, the COVID-19 vaccine was created in early 2020 in response to the rapidly growing coronavirus around the world. Today, one of the most popular forms of the COVID-19; the vaccine is by Moderna. The Moderna vaccine is FDA Approved for both adults and children. It’s a two-dose vaccine given 28 days apart.
Doctors have praised the use of the vaccine as a reduction in infections. However, the vaccine does not prevent you from getting the virus, but rather ease the impact of the symptoms.
The vaccine is highly recommended and in some areas of society, it’s mandated. Today, over 46% of the population is vaccinated for COVID-19.
Johnson & Johnson and pharmaceutical company, Pfizer have a COVID-19 vaccine on the market as an alternative to the Moderna vaccine. Seniors, children, and adults with underlining conditions are at greater risk of contracting the coronavirus and are heavily advised to take the vaccine. As more information about COVID-19 is discovered, scientists are making amazing advances in curtailing the virus. What’s new in the development of coronavirus treatment options?
Scientists Find New Potent Antibody
SARS-CoV-2 is the virus behind the coronavirus. In order to successfully combat the virus, it’s important to fight against SARS-CoV-2. The virus is responsible for devastating symptoms of the coronavirus that includes:
- shortness of breath
- muscle ache
- loss of taste or smell
These symptoms including nausea, diarrhea, fatigue, and shortness of breath make COVID-19 difficult to treat. Scientists understood the benefits of neutralizing the SARS-CoV-2 virus if they expect to combat the coronavirus. Keep reading more details below for important advances in the fight against COVID-19.
Remarkably, a scientist at the University of Pittsburg School of Medicine has been able to isolate the singular molecule of SARS-CoV-2. They’ve created an antibody that successfully and completely neutralizes the virus responsible for the coronavirus. Researchers note this is the most significant breakthrough in COVID-19 since the start of trying treatment options. The new antibody does not bind to human cells in which researchers say, will reduce the chances of negative side effects. A single antibody could be the answer to successfully treating the coronavirus. When patients are diagnosed with the coronavirus, they can be given the antibody instead of being hospitalized on a ventilator.
This major find can reduce the mass fatalities around the world. The antibody will be able to accurately treat the coronavirus in both children and adults. Like most prescribed medication, it will be taken for a set number of days to neutralize the virus. It is believed that this will be a much easier way to convince people to get treatment if they’re feeling symptoms of COVID-19.
Researchers are happy about the reduction of the use of ventilators and long-term hospitalization. Scientists now believe the worst of the pandemic will soon be behind us and many lives will be saved.
The pandemic has left many people feeling a sense of uncertainty about the coronavirus. Unfortunately, they still have reserves about the instant production of the vaccine. By isolating the potent antibody in the fight against COVID, many people feel at greater ease. Researchers are hoping to soon be able to offer the neutralizer in a prescribed pill form. This will also inadvertently help people with anxiety over the vaccine come forward for treatment for COVID. This continues to be a positive step forward in the fight against the virus as a whole. Scientists continue to cover every area of the coronavirus looking for breakthroughs in possible treatment.
Fighting the virus will require ongoing research. Researchers believe they are finally understanding the COVID virus and how it has an impact on humans. Together, we can fight the threat of COVID-19. Moreover, supplements from an online pharmacy like vitamin C and D are believed to also help in the fight against the coronavirus. Each person will have a different reaction to the coronavirus which means their treatment options will be different. As research progresses, it’s still important for us to use measures like masks, frequently washing our hands, and social distancing to combat the coronavirus.